[1] 李婷,张颖,李凤飞,等.中、低预混胰岛素类似物对2型糖尿病患者血糖波动的影响[J].东南大学学报(医学版),2017,36(3):323-327.
[2] SELVARAJAH D,KAR D,KHUNTI K,et al.Diabetic peripheral neuropathy:advances in diagnosis and strategies for screening and early intervention[J].Lancet Diabetes Endocrinol,2019,7(12):938-948.
[3] FELDMAN E L,CALLAGHAN B C,POPB S,et al.Diabetic neuropathy[J].Nat Rev Dis Primers,2019,5(1):42.
[4] CASTELLI G,DESAI K M,CANTONE R E.Peripheral neuropathy:evaluation and differential diagnosis[J].Am Fam Physician,2020,102(12):732-739.
[5] WANG J,LI H Q,XU X H,et al.The effects of once-weekly dulaglutide and insulin glargine on glucose fluctuation in pooly oral-antidiabetic controlled patients with type 2 Diabetes Mellitus[J].Biomed Res Int,2019:2682657.
[6] SONG J,WEI N,ZHAO Y,et al.Elevated glycosylated hemoglobin levels and their interactive effects on hypertension risk in nondiabetic Chinese population:a cross-sectional survey[J].BMC Cardiovasc Disord,2020,20(1):218.
[7] LIU X,XU Y,AN M,et al.The risk factors for diabetic peripheral neuropathy:a meta-analysis[J].PLoS One,2019,14(2):e0212574.
[8] 中华医学会糖尿病学分会编写组.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):64-67.
[9] 曾婷婷,严励.成人超重/肥胖合并糖尿病的综合管理[J].临床内科杂志,2020,37(9):607-610.
[10] LIU Y P,SHAO S J,GUO H D.Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy[J].Life Sci,2020,248:117459.
[11] MAYEDA L,KATZ R,AHMAD I,et al.Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease[J].BMJ Open Diabetes Res Care,2020,8(1):e000991.
[12] BRAFFETT B H,GUBITOSI-KLUG R A,ALBERS J W,et al.Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the diabetes control and complications trial/epidemiology of diabetes interventions and complications(DCCT/EDIC) study[J].Diabetes,2020,69(5):1000-1010.
[13] LEE K A,PARK T S,JIN H Y.Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy[J].Endocrine,2020,70(3):465-478.
[14] PONIRAKIS G,PETROPOULOS I N,ALAM U,et al.Hypertension contributes to neuropathy in patients with type 1 diabetes[J].Am J Hypertens,2019,32(8):796-803.
[15] LI S,ZHENG Z,TANG X,et al.Impact of HbA1c variability on subclinical left ventricular remodeling and dysfunction in patients with type 2 diabetes mellitus[J].Clin chim Acta,2020,502:159-166.doi:10.1016/j.cca.2019.12.006
[16] SU J B,ZHAO L H,ZHANG X L,et al.HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients[J].Cardiovasc Diabetol,2018,17(1):47.
[17] JIN H Y,LEE K A,PARK T S.The impact of glycemic variability on diabetic peripheral neuropathy[J].Endocrine,2016,53(3):643-648.
[18] WANG B,MU X L,ZHAO J,et al.Effects of lifestyle interventions on rural patients with type 2 diabetes mellitus[J].World J Diabetes,2020,11(6):261-268.
[19] ZHANG Y,JIANG Y,SHEN X,et al.Can both normal and mildly abnormal albuminuria and glomerular filtration rate be a danger signal for diabetic peripheral neuropathy in type 2 diabetes mellitus?[J].Neurol Sci,2017,38(8):1381-1390. |